|Articles|November 1, 1997

November 1997
Volume 3
Issue 11

When Is a Cost-Effectiveness Claim Valid? How Much Should the FDA Care?

Author(s)Bryan R. Luce, PhD, MBA, Alan L. Hillman, MD, MBA

Download PDF: When Is a Cost-Effectiveness Claim Valid? How Much Should the FDA Care?

Articles in this issue

over 28 years ago

Article

Empiric Examination of Physician Behavior in a Changing Healthcare Market

over 28 years ago

Article

Healthcare Utilization Among Women with Eating Disordered Behavior

over 28 years ago

Article

Postpartum Depression

over 28 years ago

Article

Pulmonary Rehabilitation: An Overview with Evidence for Its Utility in Chronic Obstructive Pulmonary Disease

over 28 years ago

Article

Pharmaceutical Considerations of Common Herbal Medicine

over 28 years ago

Article

Cardiovascular Drug Prescribing Patterns: Where is the Evidence of Improvement?

over 28 years ago

Article

Treatment Patterns for Heart Failure in a Primary Care Environment

over 28 years ago

Article

Referrals to General Internists and Internal Medicine Trainees in an Academic Medicine Practice

over 28 years ago

Article

Enhancement of Compliance Among Patients with Hypertension

over 28 years ago

Article

Incorporating Quality of Life Data into Managed Care Formulary Decisions: A Case Study with Salmeterol

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

When Is a Cost-Effectiveness Claim Valid? How Much Should the FDA Care?

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

5 Things to Know About the Oral GLP-1 Era

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention